Short Interest in NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Drops By 24.9%

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) saw a significant drop in short interest in the month of November. As of November 30th, there was short interest totalling 18,100 shares, a drop of 24.9% from the November 15th total of 24,100 shares. Based on an average daily trading volume, of 16,100 shares, the days-to-cover ratio is presently 1.1 days.

NLS Pharmaceutics Stock Performance

Shares of NLSPW stock traded up $0.00 during trading hours on Friday, reaching $0.01. 4,000 shares of the company’s stock were exchanged, compared to its average volume of 18,160. NLS Pharmaceutics has a fifty-two week low of $0.01 and a fifty-two week high of $0.10. The stock’s 50 day moving average is $0.01 and its 200-day moving average is $0.02.

NLS Pharmaceutics Company Profile

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).